UNITUXIN
Google image searchProduct monograph
Active ingredient
dinutuximab, 3.5 MG/ML
DIN: 02483076
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription
Company: UNITED THERAPEUTICS CORPORATION
Date: 01-MAY-2019
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
- L01FX — Other monoclonal antibodies and antibody drug conjugates (ATC, ATC/DDD)
- L01FX06 — DINUTUXIMAB BETA (ATC/DDD)
